A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

Cell

Volumn 85, Issue 3, 1996, Pages 403-414

  Kamei, Yasutomi ^d   Xu, Lan ^d   Heinzel, Thorsten ^d   Torchia, Joseph ^d   Kurokawa, Riki ^d   Gloss, Bernd ^d   Lin, Sheng Cai ^c   Heyman, Richard A ^b   Rose, David W ^a   Glass, Christopher K ^d   Rosenfeld, Michael G ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LIGAND PHARMACEUTICALS INC   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; GENE EXPRESSION REGULATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0242587820     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81118-6     Document Type: Article

References (62)

1. Abate, C., and Curran, T. (1990). Encounters with Fos and Jun on the road to AP-1. Semin. Cancer Biol. 1, 19-26.
2. Angel, P., and Karin, M. (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157.
3. Arany, Z., Sellers, W.R., Livingston, D.M., and Eckner, R. (1994). E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77, 799-800.
4. Arany, Z., Newsome, D., Oldread, E., Livingston, D.M., and Eckner, R. (1995). A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374, 81-84.
5. Arias, J., Alberts, A.S., Brindle, P., Claret, F.X., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994). Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370, 226-229.
6. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. (1994). Current Protocols in Molecular Biology (New York: Greene Publishing Association).
7. Baniahmad, A., Leng, X., Burris, T.P., Tsai, S.Y., Tsai, M.J., and O'Malley, B.W. (1995). The tau4 activation domain of the thyroid hormone receptor is required for release of a putativecorepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 15, 76-86.
8. Bannister, A.J., and Kouzarides, T. (1995). CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J. 14, 4758-4762.
9. Beato, M., Herrlich, P., and Schütz, G. (1995). Steroid hormone receptors: many actors in search of a plot. Cell 83, 851-857.
10. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H., and Mortas, D. (1995). Crystal structure of the ligand-binding domain of the human nuclear receptor RXRα. Nature 375, 377-382.
11. Brindle, P., Linke, S., and Montminy, M. (1993). Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressors. Nature 364, 821-824.
12. Bugge, T.H., Pohl, J., Lonnoy, O., and Stunnenberg, H.G. (1992). RXRα, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J. 11, 1409-1418.
13. Cavailles, V., Dauvois, S., Danielian, P.S., and Parker, M.G. (1994). Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA 91, 10009-10013.
14. Cavailles, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P. J., and Parker, M.G. (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14, 3741-3751.
15. Chambon, P. (1994). The retinoid signaling pathway: molecular and genetic analyses. Semin. Cell Biol. 5, 115-125.
16. Chen, J.D., and Evans, R.M. (1995). A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454-457.
17. Chrivia, J.C., Kwok, R.P.S., Lamb, N., Hagiwara, M., Montminy, M.R., and Goodman, R.H. (1993). Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855-859.
18. Damm, K., Heyman, R.A., Umesono, K., and Evans, R.M. (1993). Functional inhibition of retinoic acid response by dominant negative retinoicacid receptor mutants. Proc. Natl. Acad. Sci. USA. 90, 2989-2993.
19. Desbois, C., Aubert, D., Legrand, C., Pain, B., and Samarut, J. (1991). A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. Cell 67, 731-740.
20. Drapkin, R., Merino, A., and Reinberg, D. (1993). Regulation of RNA polymerase II transcription. Curr. Opin. Cell Biol. 5, 469-476.
21. Drolet, D.W., Scully, K.M., Simmons, D.M., Wegner, M., Chu, K.T., Swanson, L.W., and Rosenfeld, M.G. (1991). TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins. Genes Dev. 5, 1739-1753.
22. Eckner, R., Ewen, M.E., Newsome, D., Gerdes, M., DeCaprio, J.A., Lawrence, J.B., and Livingston, D.M. (1994). Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8, 869-884.
23. Gloss, B, and Bernard, H.-U. (1990). The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J. Virol. 64, 5577-5584.
24. Gonzalez, G.A., Menzel, P., Leonard, J., Fischer, W.H., and Montminy, M.R. (1991). Characterization of motifs which are critical for activity of the cyclic AMP-responsive transcription factor CREB. Mol. Cell. Biol. 11, 1306-1312.
25. Gorman, C.M., Moffat, L.F., and Howard, B.H. (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2, 1044-1051.
26. Gyuris, J., Golemis, Chertkov, H., and Brent, R. (1993). Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75, 791-803.
27. Halachmi, S., Marden, E., Martin, G., MacKay, I., Abbondanza, C., and Brown, M. (1994). Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264, 1455-1458.
28. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340.
29. Hansen, S.K., and Tjian, R. (1995). TAFs and TFIIA mediate differential utilization of the tandem Adh promoters. Cell 82, 565-575.
30. Hörlein, A.J., Näär, A.M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Söderström, M., Glass, C.K., and Rosenfeld, M.G. (1995). Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397-404.
31. Jonat, C., Rahmsdorf, H.J., Park, K.-K., Cato, A.C.B., Gebel, S., Ponta, H., and Herrlich, P. (1990). Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62, 1189-1204.
32. Kaelin, W.G., Jr., Krek, W., Sellers, W.R., DeCaprio, J.A., Ajchenbaum, F., Fuchs, C.S., Chittenden, T., Li, Y., Farnham, P.J., Blanar, M.A., et al. (1992). Expression cloning of a cDNA encoding a retino-blastoma-binding protein with E2F-like properties. Cell 70, 351-364.
33. Kliewer, S.A., Umesono, K., Mangelsdorf, D.J., and Evans, R.M. (1992). Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355, 446-449.
34. König, H., Ponta, H., Rahmsdorf, H.J., and Herrlich, P. (1992). Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11, 2241-2246.
35. Kurokawa, R., Söderström, M., Hörlein, A., Halachmi, S., Brown, M., Rosenfeld, M.G., and Glass, C.K. (1995). Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377, 451-454.
36. Kwok, R.P., Lundblad, J.R., Chrivia, J.C., Richards, J.P., Bächinger, H.P., Brennan, R.G., Roberts, S.G., Green, M.R., and Goodman, R.H. (1994). Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223-226.
37. Le Douarin, B., Zechel, C., Garnier, J.-M., Lutz, Y., Tora, L., Pierrat, B., Heery, D., Gronemeyer, H., Chambon, P., and Losson, R. (1995). The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14, 2020-2033.
38. Lee, J.W., Ryan, F., Swaffield, J.C., Johnston, S.A., and Moore, D.D. (1995). Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374, 91-94.
39. Lefstin, J.A., Thomas, J.R., and Yamamoto, K.R. (1994). Influence of asteroid receptor DNA-binding domain on transcriptional regulatory functions. Genes Dev. 8, 2842-2856.
40. Leid, M., Kastner, P., Lyons, R., Nakshatri, H., Saunders, M., Zacharewski, T., Chen, J.Y., Staub, A., Garnier, J.M., Mader, S., et al. (1992). Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68, 377-395.
41. Lin, C., Lin, S.-C., Chang, C.-P., and Rosenfeld, M.G. (1992). Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 360, 765-768.
42. Lucibello, F.C., Slater, E.P., Jooss, K.U., Beato, M., and Muller, R. (1990). Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J. 9, 2827-2834.
43. Lundblad, J.R., Kwok, R.P., Laurance, M.E., Harter, M.L., and Goodman, R.H. (1995). Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374, 85-88.
44. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R.M. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
45. Marks, M.S., Hallenbeck, P.L., Nagata, T., Segars, J.H., Appella, E., Nikodem, V.M., and Ozato, K. (1992).H-2RIIBP (RXRβ) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J. 11, 1419-1435.
46. Oñate, S.A., Tsai, S.Y., Tsai, M.-J., and O'Malley, B.W. (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357.
47. Peterson, C.L., and Herskowitz, I. (1992). Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode aglobal activator of transcription. Cell 68, 573-583.
48. Petrij, F., Giles, R.H., Dauwerse, H.G., Sarls, J.J., Hennekam, R.C.M., Masuno, M., Tommerup, N., van Ommen, G.-J.B., Goodman, R.H., Peters, D.J.M., and Breuning, M.H. (1995). Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348-351.
49. Renaud, J.-P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H., and Moras, D. (1995). Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689.
50. Rose, D.W., McCabe, G., Feramisco, J.R., and Adler, M. (1992). Expression of c-fos and AP-1 activity in senescent human fibroblasts is not sufficient for DNA synthesis. J. Cell Biol. 119, 1405-1411.
51. Saatcioglu, F., Claret, F.-X., and Karin, M. (1994). Negative transcriptional regulation by nuclear receptors. Semin. Cancer Biol. 5, 347-359.
52. Saitou, M., Narumiya, S., and Kakizuka, A. (1994). Alteration of a single amino acid residue in retinoic acid receptor causes dominant-negative phenotype. J. Biol. Chem. 269, 19101-19107.
53. Salbert, G., Fanjul, A., Piedrafita, F.J., Lu, X.P., Kim, S.-J., Tran, P., and Pfahl, M. (1993). Retinoic acid receptors and retinoid X receptor-a regulate the transforming growth factor-β1 promoter by antagonizing AP-1 activity. Mol. Endocrinol. 10, 1347-1356
54. Schüle, R., Rangarajan, P., Kliewer, S., Ransone, L.J., Bolado, J., Yang, N., Verma, I.M., and Evans, R.M. (1990). Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62, 1217-1226.
55. Tsai, M.J., and O'Malley, B.W. (1994). Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486.
56. Tzukerman, M., Zhang, X.-K., and Pfahl, M. (1991). Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate: a molecular analysis. Mol. Endocrinol. 91, 1983-1992.
57. Vinson, C.R., LaMarco, K.L., Johnson, P.F., Landschulz, W.H., and McKnight, S.L. (1988). In situ detection of sequence-specific DNA binding activity specified by a recombinant bacteriophage. Genes Dev. 2, 801-806.
58. Wagner, R.L., Apriletti, J.W., McGrath, M.E., West, B.L., Baxter, J.D., and Fletterick, R.J. (1995). A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697.
59. Winston, F., and Carlson, M. (1992). Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends Genet. 8, 387-391.
60. Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L, Smeal, T., Schmidt, T.J., Drouin, J., and Karin, M. (1990). Transcriptional interference between c-Jun and the glucocorticoid receptors: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62, 1205-1215.
61. Yu, V.C., Delsert, C., Andersen, B., Holloway, J.M., Devary, O.V., Näär, A.M., Kim, S.Y., Boutin, J.M., Glass, C.K.,and Rosenfeld, M.G. (1991). RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67, 1251-1266.
62. Zhang, X.K., Hoffman, B., Tran, P.B., Graupner, G., and Pfahl, M. (1992). Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355, 441-446.